Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Delorbis Pharmaceuticals LtdDelorbis Pharmaceuticals Ltd
VS
Merck GroupMerck Group
Delorbis Pharmaceuticals Ltd

Delorbis Pharmaceuticals Ltd

17, Athinon Street Ergates Industrial Area, Lefkosia, 2643, CY

Last Update: 01/04/2026

View Profile
Between 750 and 799
http://www.delorbispharma.eu
753/1000Fair

DELORBIS as a leading European pharmaceutical company, offers a broad portfolio of more than 100 branded medicines. At DELORBIS, we are dedicated to offer: -Better Affordability of European high-quality medicines, -Better Availability throughout the world and, -Bette...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:133
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0
Merck Group

Merck Group

Frankfurter Str. 250, Darmstadt, DE, 64293

Last Update: 07/04/2026

View Profile
Between 650 and 699
http://www.merckgroup.com
674/1000Weak

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, U...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:32,268
Subsidiaries:3
12-month incidents
0
Known data breaches
0
Attack type number
1

Compliance Ranges Comparison

Based On Specific Ai Models Category
Delorbis Pharmaceuticals Ltd

Delorbis Pharmaceuticals Ltd

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Merck Group

Merck Group

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Delorbis Pharmaceuticals Ltd in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Merck Group in 2026.

Incidents

Incident History - Delorbis Pharmaceuticals Ltd (X = Date, Y = Severity)

Delorbis Pharmaceuticals Ltd cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Merck Group (X = Date, Y = Severity)

Merck Group cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Delorbis Pharmaceuticals Ltd

Delorbis Pharmaceuticals Ltd

Incidents
No explicit notable incidents reported.
Merck Group

Merck Group

Incidents
🔒 Incident : Ransomware
MEREQUUNIMAEMGMGOOTOYSNOALLORARIPTIC1775528897

FAQ

Between Delorbis Pharmaceuticals Ltd company and Merck Group company, which one has the best AI Cybersecurity Score ?
Between Delorbis Pharmaceuticals Ltd company and Merck Group company, which one has experienced more cyber incidents in the past ?
Between Delorbis Pharmaceuticals Ltd company and Merck Group company, which one has experienced more cyber incidents this year ?
Between Delorbis Pharmaceuticals Ltd company and Merck Group company, which one has experienced at least one ransomware attack ?
Between Delorbis Pharmaceuticals Ltd company and Merck Group company, which one has experienced at least one data breach ?
Between Delorbis Pharmaceuticals Ltd company and Merck Group company, which one has experienced at least one targeted cyberattack ?
Between Delorbis Pharmaceuticals Ltd company and Merck Group company, which one has experienced at least one vulnerability ?
Between Delorbis Pharmaceuticals Ltd company and Merck Group company, which one holds the most compliance certifications ?
Between Delorbis Pharmaceuticals Ltd company and Merck Group company, which one holds the fewest compliance certifications ?
Between Delorbis Pharmaceuticals Ltd company and Merck Group company, which one has the most subsidiaries ?
Between Delorbis Pharmaceuticals Ltd company and Merck Group company, which one has the largest number of employees ?
Between Delorbis Pharmaceuticals Ltd and Merck Group, which company holds both SOC 2 Type 1 certifications ?
Between Delorbis Pharmaceuticals Ltd and Merck Group, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Delorbis Pharmaceuticals Ltd or Merck Group ?
Which company is PCI DSS compliant - Delorbis Pharmaceuticals Ltd or Merck Group ?
Between Delorbis Pharmaceuticals Ltd and Merck Group, which company complies with HIPAA regulations for healthcare data ?
Between Delorbis Pharmaceuticals Ltd and Merck Group, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-56082
SUMMARY

Capgo (Cap-go/capgo) before 12.128.2 contains an improper access control vulnerability in the SECURITY DEFINER PostgREST RPC function public.record_build_time, which is granted to the anon role and callable with only the public Supabase publishable (sb_publishable_*) anon key. An unauthenticated attacker can insert rows into public.build_logs for arbitrary organizations and, because the function uses ON CONFLICT (build_id, org_id) DO UPDATE, can overwrite existing usage/billing records by reusing the same build_id for a target org. This enables cross-tenant tampering of billing build logs and financial-impact denial of service by inflating billable build time.

PUBLISHED
Date2026-06-19
UPDATED
Date2026-06-19
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:N
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
3.9
CVE-2026-56081
SUMMARY

Cap-go before 12.128.2 contains an authentication logic flaw that lets an attacker register and control an account bound to a victim's email address before that email is verified. By enabling two-factor authentication on the pre-registered account, the attacker gains control over the account claimed under the victim's identity, allowing them to read and modify its state and enforce organization-level policies, while the legitimate user is denied access to the account tied to their own email.

PUBLISHED
Date2026-06-19
UPDATED
Date2026-06-19
RISK INFORMATION (Score: 9.1)
CVSS3
Base Score: 9.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N
CVSS4
Base Score: 9.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.2
EXPLOITABILITY
3.9
CVE-2026-56080
SUMMARY

Capgo before 12.128.2 contains a flaw in the Enforce Password Policy feature: after a Super Admin enables the policy and successfully changes their password to a compliant one, the backend does not update the password-compliance state. As a result, the backend continues to treat the account as non-compliant and repeatedly forces password-reset prompts, permanently locking the Super Admin out of organization access (organization lockout / denial of service) despite valid authentication.

PUBLISHED
Date2026-06-19
UPDATED
Date2026-06-19
RISK INFORMATION (Score: 4.9)
CVSS3
Base Score: 4.9
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:N/I:N/A:H
CVSS4
Base Score: 6.9
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
1.2
CVE-2026-56079
SUMMARY

Capgo before 12.128.2 contains a cross-tenant authorization bypass vulnerability in PostgREST endpoints that allows org-scoped read API keys to access other tenants' webhook secrets and delivery logs. Attackers can query the webhooks and webhook_deliveries endpoints to exfiltrate HMAC signing secrets and delivery payloads, enabling forged webhook events against victim organizations.

PUBLISHED
Date2026-06-19
UPDATED
Date2026-06-19
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
CVSS4
Base Score: 7.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
CVE-2026-56073
SUMMARY

Cap-go before 12.128.2 contains an authentication bypass vulnerability in OTP verification that allows attackers to bypass email verification by modifying server responses. Attackers can intercept OTP verification requests and manipulate HTTP responses to falsely mark verification successful, enabling unauthorized 2FA enablement and account takeover.

PUBLISHED
Date2026-06-19
UPDATED
Date2026-06-19
RISK INFORMATION (Score: 9.4)
CVSS3
Base Score: 9.4
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:L
CVSS4
Base Score: 9.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.5
EXPLOITABILITY
3.9